{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-259357","form_type":"8-K","ticker":"EEX","cik":"0001579214","company_name":"Emerald Holding, Inc.","filed_at":"2025-10-31T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.809964+00:00","generated_at":"2026-05-17T01:06:40.522535+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Emerald Q3 revenue up 6.7% but organic down 6.8%; raises full-year guidance after Generis acquisition","bullets":["Q3 revenue $77.5M (+6.7% YoY); net loss $14.4M vs $11.1M loss prior year.","Organic revenue fell 6.8% to $64.0M; YTD organic up 1.0% to $288.8M.","Full-year guidance raised: revenue $460-465M, Adj. EBITDA $122.5-127.5M.","Board expanded share repurchase to $25.0M through Dec 2026; Q3 bought 116K shares at $4.87 avg.","Dividend declared $0.015/share payable Nov 20, 2025 to holders Nov 10, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-259357","json":"https://secwatch.observer/filing/0001193125-25-259357.json","markdown":"https://secwatch.observer/filing/0001193125-25-259357.md","text":"https://secwatch.observer/filing/0001193125-25-259357.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1579214/000119312525259357/0001193125-25-259357-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1579214/000119312525259357/eex-20251031.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T01:06:40.522535+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}